News
Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback